MedPath

Vancomycin

These highlights do not include all the information needed to use VANCOMYCIN INJECTION safely and effectively. See full prescribing information for VANCOMYCIN INJECTION. VANCOMYCIN injection, for intravenous use or oral use Initial U.S. Approval: 1958

Approved
Approval ID

5105259a-c16e-4875-a920-50fefc92b822

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 10, 2021

Manufacturers
FDA

Xellia Pharmaceuticals USA LLC

DUNS: 116768762

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Vancomycin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70594-040
Application NumberNDA213895
Product Classification
M
Marketing Category
C73594
G
Generic Name
Vancomycin
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateSeptember 10, 2021
FDA Product Classification

INGREDIENTS (1)

VANCOMYCINActive
Quantity: 5 g in 100 mL
Code: 6Q205EH1VU
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Vancomycin - FDA Drug Approval Details